Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis

被引:135
作者
Zhang, Ming [1 ]
Lv, Xiaoyan [3 ]
Li, Jing [1 ]
Meng, Zhaojie [1 ]
Wang, Qiujing [4 ]
Chang, WenGuang [1 ]
Li, Wei [1 ,5 ]
Chen, Li [1 ]
Liu, Yanjun [1 ,2 ]
机构
[1] Jilin Univ, Dept Pharmacol, Norman Bethune Med Coll, Changchun 130021, Peoples R China
[2] Charles R Drew Univ Med & Sci, Div Endocrinol Metab & Mol Med, UCLA Sch Med, Los Angeles, CA 90059 USA
[3] Jilin Univ, Clin Lab, Hosp 2, Changchun 130021, Peoples R China
[4] Jilin Univ, Expt Ctr Funct Sci, Norman Bethune Med Coll, Changchun 130021, Peoples R China
[5] Jilin Agr Univ, Coll Chinese Med Mat, Changchun 1300118, Peoples R China
基金
中国国家自然科学基金;
关键词
Berberine; Sodium caprate; AMP-activated protein kinase; Diabetes; Hepatic gluconeogenesis; Metabolic syndrome; ACTIVATED PROTEIN-KINASE; GLUCOSE-UPTAKE; DIABETES-MELLITUS; COACTIVATOR TORC2; INSULIN; MECHANISM; METABOLISM; TRANSPORT; EFFICACY; RATS;
D O I
10.1016/j.mce.2012.08.006
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Berberine (HER), a natural product and active ingredient of genera Berberis and Coptis, has been demonstrated to possess anti-diabetic activities. However, the poor bioavailability of this agent greatly limits its clinical application. In our previous study, we demonstrated that co-administration of sodium caprate, an absorption enhancer, with BER could significantly increase the bioavailability of BER without any serious mucosal damage. Here, we investigated the effects of BER on AMP-activated protein kinase (AMPK)/gluconeogenesis pathway and the effects of sodium caprate on hypoglycemic action of BER. The ability of BER co-administered with sodium caprate to reduce insulin resistance was investigated in diabetic rat model induced by high-fat diet and low dose STZ. Western blot was performed to evaluate effects of BER on AMPK signaling proteins involved in hepatic gluconeogenesis in diabetic rat and HepG2 hepatocytes. BER reduced body weight and caused a significant improvement in glucose tolerance without altering food intake in diabetic rats. Similarly, BER reduced plasma triglycerides and improved insulin action in diabetic rats. BER down-regulated the elevated expressions of gluconeogenesis key enzymes PEPCK and G6Pase, inhibited the translocation of TORC2 from cytoplasm to nucleus and increased AMPK activity in liver tissues. The effect of BER was higher when co-administered with sodium caprate. BER treatment resulted in reduced glucose production in HepG2 hepatocytes. BER increased AMPK activity, reduced the expression of PEPCK, and the nuclear transcription factors PGC-1. HNF-4 alpha and FOXO1. The effect of BER on gluconeogenesis could be partly blocked by AMPK inhibitor, Compound C. HER could suppress hepatic gluconeogenesis in rat model of diabetes at least in part via stimulation of AMPK activity and this action of BER is augmented by sodium caprate. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:122 / 130
页数:9
相关论文
共 25 条
[1]
Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine [J].
Brusq, Jean-Marie ;
Ancellin, Nicolas ;
Grondin, Pascal ;
Guillard, Raphaelle ;
Martin, Sandrine ;
Saintillan, Yannick ;
Issandou, Marc .
JOURNAL OF LIPID RESEARCH, 2006, 47 (06) :1281-1288
[2]
Berberine inhibits PTP1B activity and mimics insulin action [J].
Chen, Chunhua ;
Zhang, Yuebo ;
Huang, Cheng .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 397 (03) :543-547
[3]
Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK [J].
Cheng, Zhe ;
Pang, Tao ;
Gu, Min ;
Gao, An-Hui ;
Xie, Chuan-Ming ;
Li, Jing-Ya ;
Nan, Fa-Jun ;
Li, Jia .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2006, 1760 (11) :1682-1689
[4]
Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2 [J].
Dentin, Renaud ;
Liu, Yi ;
Koo, Seung-Hoi ;
Hedrick, Susan ;
Vargas, Thomas ;
Heredia, Jose ;
Yates, John, III ;
Montminy, Marc .
NATURE, 2007, 449 (7160) :366-+
[5]
Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes [J].
Kim, So Hui ;
Shin, Eun-Jung ;
Kim, Eun-Do ;
Bayaraa, Tsenguun ;
Frost, Susan Cooke ;
Hyun, Chang-Kee .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (11) :2120-2125
[6]
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism [J].
Koo, SH ;
Flechner, L ;
Qi, L ;
Zhang, XM ;
Screaton, RA ;
Jeffries, S ;
Hedrick, S ;
Xu, W ;
Boussouar, F ;
Brindle, P ;
Takemori, H ;
Montminy, M .
NATURE, 2005, 437 (7062) :1109-1114
[7]
Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states [J].
Lee, Yun S. ;
Kim, Woo S. ;
Kim, Kang H. ;
Yoon, Myung J. ;
Cho, Hye J. ;
Shen, Yun ;
Ye, Ji-Ming ;
Lee, Chul H. ;
Oh, Won K. ;
Kim, Chul T. ;
Hohnen-Behrens, Cordula ;
Gosby, Alison ;
Kraegen, Edward W. ;
James, David E. ;
Kim, Jae B. .
DIABETES, 2006, 55 (08) :2256-2264
[8]
Leng SH, 2004, ACTA PHARMACOL SIN, V25, P496
[9]
The pivotal role of protein kinase C zeta (PKCzeta) in insulin- and AMP-activated protein kinase (AMPK)-mediated glucose uptake in muscle cells [J].
Liu, Li-Zhong ;
Cheung, Stanley C. K. ;
Lan, Lin-Lin ;
Ho, Stanley K. S. ;
Chan, Juliana C. N. ;
Tong, Peter C. Y. .
CELLULAR SIGNALLING, 2010, 22 (10) :1513-1522
[10]
Berberine modulates insulin signaling transduction in insulin-resistant cells [J].
Liu, Li-Zhong ;
Cheung, Stanley C. K. ;
Lan, Lin-Lin ;
Ho, Stanley K. S. ;
Xu, Hong-Xi ;
Chan, Juliana C. N. ;
Tong, Peter C. Y. .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2010, 317 (1-2) :148-153